He was diagnosed with multiple myeloma December 18, 2012. On January 1, 2013 he started a chemotherapy regime which would go on through April 2013. That led to a stem cell transplant in May of that same year. Scott continues to battle MM...
About Multiple Myeloma:
Multiple myeloma (more commonly known as myeloma) is a blood cancer that affects the production of plasma cells in bone marrow. Although not well known to the general public, myeloma is the second most common blood cancer. Approximately 24,000 are diagnosed annually in the US alone. For new patients, as well as those living with the disease for years, myeloma is life changing. The symptoms are constant and ongoing: bone pain, extreme fatigue, nausea, numbness in the hands and/or feet, kidney problems and infections. IMF research supports the development of new drug therapies. These therapies have helped prolong lives, but myeloma continues to be an incurable disease.Your support will help fund research that could possibly find a cure for this disease.
For further information please visit: http://online.myeloma.org
We are pleased to announce that, $50,000
has been donated from the first two outings to:
Giada Bianchi, MD – Boston, MA
Dana-Farber Cancer Institute
Jerome Lipper Multiple Myeloma Center
“Investigating the Role of Robo1 in Migration and Homing in Multiple Myeloma”
Abstract: Multiple myeloma (MM) is a tumor of blood cells characterized by excessive growth of cancer cells in numerous spots within the bone marrow (BM). The protein Roundabout1 (Robo1) induces proliferation, metastasis and new vessel formation in solid tumors, and drugs are under development. Published data suggest Robo1 is important in MM development. Our initial studies support a role for Robo1 in MM trafficking within the BM. This project will study how Robo1 mediate MM dissemination using cell culture and animal models to devise novel treatments.